Professional Seasonal Analysis for Trading

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA)

Seasonality Analysis

Stocks 23 Years Analyzed

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Annual Seasonality Statistics

21.79%
Avg Annual Return
31.9%
Avg Monthly Win Rate
8/12
Positive Months
23
Years Analyzed

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -0.29%
26%
Very Weak
February 3.12%
39%
Weak
March 1.37%
30%
Weak
April 1.37%
30%
Weak
May WORST -2.72%
27%
Very Weak
June 1.23%
23%
Weak
July -0.14%
18%
Very Weak
August BEST 8.26%
41%
Weak
September 3.96%
39%
Weak
October -0.29%
43%
Weak
November 5.13%
39%
Weak
December 0.79%
26%
Weak

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for SVA with overlay patterns, custom date ranges, and more.

Create Free Account

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Seasonal Historical Performance

Historical Performance

See historical average returns for SVA across multiple timeframes.

Create Free Account

About Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) Seasonality

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) has been analyzed using 23 years of historical data to identify seasonal patterns. Classified under Stocks, Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) shows distinct seasonal tendencies based on historical data.

The strongest month for Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) is historically August, with an average return of 8.26% and a win rate of 41%. Conversely, May tends to be the weakest month, averaging -2.72% return.

Looking at the full calendar year, Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) has an average annual return of 21.79% with an overall monthly win rate of 31.9%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) has a consistency score of 56.4 (Fair), based on 24 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Seasonality FAQ

What is the best month to buy Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA)?

Historically, August has been the best month for Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo), with an average return of 8.26% and a win rate of 41%. However, past performance does not guarantee future results.

What is the worst month for Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA)?

Based on historical data, May has been the weakest month for Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo), with an average return of -2.72%. This is a historical observation and does not guarantee future results.

How reliable is SVA seasonality data?

The seasonality analysis for Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) is based on 23 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) seasonality in my trading?

Use Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.